11C-erlotinib

You have access
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, Cécile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger and Oliver Langer

Journal of Nuclear Medicine April 1, 2019, 60 (4) 486-491; DOI: https://doi.org/10.2967/jnumed.118.216432
You have access
Quantitative and Simplified Analysis of ¹¹C-Erlotinib Studies
Maqsood Yaqub, Idris Bahce, Charlotte Voorhoeve, Robert C. Schuit, Albert D. Windhorst, Otto S. Hoekstra, Ronald Boellaard, N. Harry Hendrikse, Egbert F. Smit and Adriaan A. Lammertsma

Journal of Nuclear Medicine June 1, 2016, 57 (6) 861-866; DOI: https://doi.org/10.2967/jnumed.115.165225
You have access
Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of ¹¹C-Erlotinib
Alexander Traxl, Thomas Wanek, Severin Mairinger, Johann Stanek, Thomas Filip, Michael Sauberer, Markus Müller, Claudia Kuntner and Oliver Langer

Journal of Nuclear Medicine December 1, 2015, 56 (12) 1930-1936; DOI: https://doi.org/10.2967/jnumed.115.161273

Main menu